3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Non Small Cell Lung Carcinoma NSCLC
2
Uterine Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Interventions
ponatinib
4
pembrolizumab
3
Rituximab
3
Gemcitabine
3
Cyclophosphamide
3
130-nm albumin-bound paclitaxel
3
pralsetinib
2
napabucasin
2
Vincristine
2
Prednisone
2
Irinotecan
2
Imatinib Mesylate
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
Brentuximab Vedotin
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
ricolinostat
1
pomalidomide
1
pamiparib
1
nirogacestat
1
nilotinib
1
ibritumomab tiuxetan
1
denileukin diftitox
1
bosutinib
1
blinatumomab
1
Vorinostat
1
Temozolomide
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Histologic Type
×
CP protocol
×
Clear all
No trials found.